key: cord-0725451-576qc2yv
authors: Tastanova, Aizhan; Stoffel, Corinne Isabelle; Dzung, Andreas; Cheng, Phil Fang; Bellini, Elisa; Johansen, Pål; Duda, Agathe; Nobbe, Stephan; Lienhard, Reto; Bosshard, Philipp Peter; Levesque, Mitchell Paul
title: A comparative study of real-time RT-PCR-based SARS-CoV-2 detection methods and its application to human-derived and surface swabbed material
date: 2021-05-05
journal: J Mol Diagn
DOI: 10.1016/j.jmoldx.2021.04.009
sha: 05b9a319bcef96995c31bfdcbea810ff15bd65b4
doc_id: 725451
cord_uid: 576qc2yv

Real-time reverse transcription polymerase chain reaction (RT-PCR) remains a gold standard in detection of various viral diseases. In the COVID-19 pandemic, multiple RT-PCR based tests were developed to screen for viral infection. As an emergency response to growing testing demand, we established a SARS-CoV-2 PCR diagnostics platform for which we compared different commercial and in-house RT-PCR protocols. Four commercial (CDC 2019-nCoV, Applied BiosystemsTM 2019-nCoV Assay Kit v1 TF-SinglePlex, 2019-nCoV Assay Kit v2 TF-MultiPlex, and EURORealTime SARS-CoV-2), one customized (Institute Pasteur), and one in-house RT-PCR protocols were evaluated with 92 SARS-CoV-2 positive and 92 SARS-CoV-2 negative samples. Furthermore, economical and practical characteristics of these protocols were compared. Additionally, a highly sensitive digital droplet PCR (ddPCR) method was developed and application of RT- and ddPCR methods on SARS-CoV-2 environmental samples was examined. Very low limits of detection (1 or 2 viral copies/μL), high sensitivities (93.6-97.8%) and specificities (98.7-100%) for the tested RT-PCR protocols were found. Furthermore, the feasibility of downscaling two of the commercial protocols, which could optimize testing capacity was demonstrated. Tested commercial and customized RT-PCR detection kits show very good and comparable sensitivity, and specificity, and the kits could be further optimized for use on SARS-CoV-2 viral samples derived from human and surface swabbed samples.

States)) at 4 °C for max. 48 hours or stored at -80°C until further analyses. All household swabbing participants provided informed consent for the study and both the assay establishment and household studies were approved by the Cantonal Ethics Committee: BASEC-Nr-2020-00660 and BASEC-Nr-2020-00659, respectively.

Viral RNA was extracted as previously described 5 using magnetic bead-based (SpeedBeads, GE Healthcare, Darmstadt, Germany) extraction kit for KingFisher instrument (MagMax, Thermo Fisher, Waltham, Massachusetts, U.S).

Four commercially available, one customized from Pasteur Institute and in-house optimized RT-PCR protocols (description available in Table 1 ) 6, 7 were compared. Primer probes design, reaction mix and thermal cycling conditions are shown in Table 2 and RNase P (HEX) (primer sequences can be found in Table 2 . Briefly, 20 µL of reaction mix For sensitivity and specificity value calculations of each assay, the results of RT-PCR obtained from the ADMed Laboratory (La Chaux-de-Fonds) were used as gold standard reference. The sensitivity was defined with the following formula "TP/(TP+FN)", while specificity was defined as "TN/(TP+FP)"

where: TP is true positive, FP is false positive, TN is true negative, and FN is false negative. If the result of tested assays matched the reference, it was labeled concordant. If the result from the tested assays did not match the gold reference, it was labeled discordant. Inconclusive results were excluded from sensitivity and specificity calculations.

The viral infectivity assay was performed as previously described 8 The six RT-PCR protocols compared in this study utilize the same principle of isolating viral RNA from the nasopharyngeal and/or oropharyngeal swabs or bronchial fluid and running a 1-step reverse transcription reaction followed by real time amplification of two or three SARS-CoV-2 target genes ( Figure 1 ). Summary and comparison of all tested RT-PCR protocols is shown in Due to unspecific E-gene amplification (Supplemental Table S1 ), the protocol developed by Pasteur institute in Paris was not used further in this comparative study.

Limit of detection of real-time RT-PCR and ddPCR SARS-CoV-2 detection protocols With a Ct-value cut-off of 40, the five RT-PCR SARS-CoV-2 detection protocols (CDC, TF-MultiPlex, TF-SinglePlex, Euroimmun, Oncobit) as well as Oncobit ddPCR protocol showed limit of detection (LoD) between 1 and 2 viral copies/μL (Figure 2A Table S2 ) and 70 samples tested negative for all listed respiratory diseases including SARS-CoV-2. All protocols, except TF-SinglePlex, J o u r n a l P r e -p r o o f showed no cross reactivity ( Figure 3A ) including samples that were positive for four other types of corona viruses (Supplemental Table S2 ). The specificity was thus 100% for all protocols except for TF-SinglePlex, which had a specificity of 98.7% ( Figure 3A ).

Inconclusive results were found in 0.5-3.2% of these 184 samples, with TF-MultiPlex and Oncobit providing the most accuracy ( Figure 3A ). Comparing RT-PCR results (positive, negative, inconclusive) of all 184 samples, the overall non-concordance between all the protocols was 14.7% ( Figure 3B ).

To optimize testing capacity, (i) recommended reaction volumes in commercial protocols were downscaled and (ii) published primer/probe sequences were customized to have an in-house developed protocol (Oncobit). Using a previously confirmed SARS-CoV-2 positive cohort of 14 samples, CDC and TF-MultiPlex protocols with recommended reaction volume and with reaction volumes reduced by 50% were compared. RNA sample input was always the same. The Oncobit protocol was the cheapest (Table 6) , had the shortest RT-PCR reaction time requirement (Table 6) and had most reliable access to consumables (Microsynth). The specificity and sensitivity of the Oncobit protocol was comparable to other commercial SARS-CoV-2 RT-PCR detection kits ( Figure   3A ,B).

A downscaled CDC protocol showed two (14.3%) inconclusive results, a standard TF-MultiPlex protocol showed one (7.1%) false negative result, and a downscaled TF-MultiPlex protocol revealed one (7.1%) false negative as well as one (7.1%) inconclusive result ( Figure 4A ). Furthermore, LoD of downscaled CDC and TF-MultiPlex protocols showed a sensitivity of 1 copy/μL with a Ct-value cut-off of 40 ( Figure 4B ).

Having compared and established the RT-PCR protocols for SARS-CoV-2 diagnostics, possibility of application of RT-PCR and ddPCR protocol for SARS-CoV-2 detection on environmental samples was examined. Swabs of different surfaces from a SARS-CoV-2 quarantined household were collected and analyzed by two validated RT-PCR protocols. Additionally, an in-house ddPCR protocol was developed to accurately detect and quantify virus.

On the day of household surface swabbing (25 th of April 2020) of SARS-CoV-2 positive family, only the P2 was swabbed again and tested positive, but reported no symptoms (Supplemental Figure   S1A ). The pharyngeal swab as well as swabbed surface samples were collected on the same day and tested with three different SARS-CoV-2 detection protocols (CDC, TF-MultiPlex, and ddPCR).

Pharyngeal swab was tested positive (cycle thresholds >30) on three different protocols. The laptop keyboard and two more swabbed surface (the door handle and newspaper) samples showed positive and inconclusive results, respectively (Supplemental Table S3 ), while no infectivity for any of the samples was detected (Supplemental Figure S1B ).

Real time RT-PCR remains the most sensitive method for early detection of SARS-CoV-2. Here, we report a comparison of LoD, specificity, sensitivity, economic, and practical advantages of four commercial SARS-CoV-2 detection kits as well as one optimized in house RT-PCR SARS-CoV-2 protocol.

A study comparing RT-PCR to rapid fluorescence immunochromatographic (FIC) assay-based SARS-CoV-2 Nucleocapsid protein (NP) antigen detection method showed that sensitivity of the rapid method was only around 75.6% 11 , therefore RT-PCR remains a more sensitive detection method for SARS-CoV-2. Most of the reported multiplatform comparison studies on real time RT-PCR SARS-CoV-2 detection performed the benchmarking only on limited number of samples and tested only commercial detection kits 10, 12, 13 , and some studies limited the comparison only to sensitivity assessment 14 .

In this study, a low LoD and high sensitivity for four commercial SARS-CoV-2 RT-PCR detection protocols were observed by using standard quantitative test samples and a cohort of 92 SARS-CoV-2 positive samples, respectively. Furthermore, specificity of those protocols was tested and confirmed with 92 samples that either had confirmed SARS-CoV-2 negative result or were collected in prepandemic times from patients presenting with respiratory symptoms (listed in Supplemental Table   S2 ).

Additionally, downscaling of two commercial protocols that were chosen for the diagnostic routine (CDC and TF-MultiPlex), could be an option to save resources. This is especially important in times when a high demand for SARS-CoV-2 testing causes supply chain problems as occurred at the beginning of the pandemic in Europe. As an alternative strategy to optimize costs and increase testing capacity, an in-house protocol was developed in collaboration with the diagnostics company Oncobit by adapting previously published primer sequences for multiplex analysis. The customized Oncobit potocol was the least costly and fastest protocol when compared to other commercial RT-PCR protocols tested in this study.

To expand the application of RT-PCR based detection protocols, a testing of swabbed surfaces from a SAR-CoV-2 quarantined household was performed. Results showed that RT-PCR protocols detected the viral genetic material on the laptop keyboard and this result was confirmed by a more sensitive ddPCR method. Two more surfaces showed inconclusive results (a newspaper and a door handle, with viral copies detectable by ddPCR, however below the limit of detection (Supplemental Table S3 ). Nasopharyngeal swab taken on the same day tested positive, however infectivity assay for all samples showed negative results. This demonstrates possibility to apply the RT-PCR based protocols on non-patient samples that could be of use for larger environmental studies.

Summarizing the comparative study, we demonstrated that most commercial and customized RT-PCR based detection protocols are highly effective at detecting viral presence in classical nasopharyngeal and/or oropharyngeal swabs and due to its high sensitivity can be applied to testing of environmental samples. 

RNaseP probe (HEX) 5'-TTCTGACCTGAAGGCTCTGCGCG-3' 

ORF1ab forward primer (100µM) 0.06µL

ORF1ab reverse primer (100µM) 0.06µL

RNaseP forward primer (100µM) 0.03µL

RNaseP reverse primer (100µM) 0.03µL

Total 20.0µl J o u r n a l P r e -p r o o f We also developed a highly sensitive digital droplet PCR (ddPCR) method. Finally, we conducted a local environmental study for the presence and infectivity of SARS-CoV-2 on different surfaces in a quarantined household using RT-and ddPCR methods. We found very low limits of detection (1 or 2 viral copies/μL), high sensitivities (93.6-97.8%) and specificities (98.7-100%) for the tested RT-PCR protocols. We demonstrated the feasibility of downscaling two of the commercial protocols, which could optimize testing capacity. In the local environmental study, only one surface sample tested positive for viral RNA, but without detectable infectivity in vitro. In conclusion, the commercial and customized RT-PCR detection kits show very good and comparable sensitivity and specificity; the kits could be further downscaled to save costs and optimized for use on SARS-CoV-2 viral samples derived from human and surface swabbed samples.

We greatly appreciate the effort to improve our manuscript and thank the reviewers for their thoughtful comments and remarks. Since both reviewers found that multi-platform comparison could be useful (Reviewer 1) and interesting (Reviewer 2) for the laboratories and readers of JMD we re-focused the manuscript on the comparative analyses of various diagnostics assays. We agree that data from one household it is not enough to make any general statements; therefore, we moved the results of testing of the swabbed surfaces from a quarantined household into the supplementary material. However, we would like to propose that we keep it in the manuscript as a demonstration that RT-PCR based methods (real time RT-PCR and ddPCR) could be employed for testing environmental samples and this could be interesting for researchers who would like to conduct such studies.

Therefore, we have addressed every issue to improve and clarify the manuscript by editing the text related to the 2 nd part where we applied the RT-PCR based method to the environmental study. Please find below our detailed point-by-point response (in blue) to all comments (in black).

Reviewer #1: In this manuscript, the authors report the evaluation of six different SARS-CoV-2 RT-PCR assay: four commercial, one customize and one in house assay. The assays describe in the paper were shown to be specific to SARS-CoV-2 and comparable in sensitivity. They also demonstrated the feasibility of downscaling commercial assays. This analysis may be useful for laboratories who wishes to maximize testing capacities. Furthermore, the use of valid SARS-CoV-2 diagnostic assay is essential for the management of the pandemic .It is critical for to ensure timely contact tracing and limit the transmission SARS-CoV-2. The authors also conducted an environmental study for the presence and infectivity of SARS-CoV-2 in a quarantined household using RT-and ddPCR methods. Results of the environmental studies were limited to one household. More testing would be required in order to draw valuable conclusions. I also find that the addition of the environmental data does not add to the paper. It is disconnected from the main objective of the paper that was to compare the diagnostic assays. The authors should consider removing it from the paper. I think that this manuscript would be of value to the readership of the Journal of Molecular Diagnostics.

We appreciate the reviewer's positive feedback and agree that the comparison, downscaling of commercial protocols, as well as in-house developed methods are useful to other laboratories to optimize and maximize their testing capacities during the COVID19 pandemic. Additionally we would like to highlight that we conducted testing of environmental samples to expand the application of RT-PCR based detection methods. We completely agree that it is hard to extrapolate from one household. Therefore, we kept this part about testing environmental samples but substantially changed the text in the results and discussion sections. We describe that surface swabs from a quarantined household were only used to show additional applications of PCR based methods that could be sensitive enough and hence useful for researchers who wish to study the environmental situation related to current pandemic (or other infections).

Reviewer #2: Tastanova et al compared 6 real-time RT-PCR based SARS-CoV-2 detection methods and found very low limits of detection, high sensitivities and specificities for the tested RT-PCR protocols. Meanwhile, one COVID-19 patient family was followed and the environmental samples were taken to evaluate the infectivity of positive RT-PCR samples. Multiplatforms comparison is not novel although the platforms evaluated in this manuscript could be new. Nevertheless, following a COVID-19 patient and their family members with sampling surface areas of the family is interesting. Unfortunately, only one point of environmental samples was taken. I would suggest the manuscript focus on the second part of the study, have a better design on multiple stages of the patient and environmental samples taken (symptomatic and recovery stages, asymptomatic family members, etc. ) to run both PCR and infectivity assay.

We are grateful for the positive feedback and a constructive evaluation of our study. We agree that there are some similar studies that have been reporting various comparative studies since the beginning of the pandemic However, most of those reports compared only commercial detection kits, evaluated only limited number of samples, and did not report any up-scaling strategies (such as downscaling) or only tested the sensitivity of the kits 1-4 . In addition to patients' samples, we wanted to demonstrate the application of RT-PCR based methods to test environmental samples for viral presence, and we developed a ddPCR test which is demonstrated here. We agree that following a COVID-19 patient and their household for viral presence is very interesting and deserves a separate study and out of scope for the multiplatform comparison manuscript. Therefore, we would like to keep it as supplementary material to show the applicability of RT-PCR and ddPCR detection methods to not only patient derived but also environmental samples.

Additionally we addressed the comments of the Editor:

Supplemental Table 2 needs to be incorporated into the main text, as it contains sequence information.

Supplemental table is now Table 1 . Figure 1B is a table and needs to be removed from the image and presented as such. Tables need to be provided in black and white, with no background formatting. Table from Figure 1B is now Table 2. 3.

References will need to be updated according to Journal style. a. Non-literature sources, such as CDC or WHO guidelines, need to be removed from the reference list and the link to access the information relocated to the appropriate place in-line in the text along with a date of last access.

b. Citations with DOIs from pre-print servers or Articles ahead of Print postings should be checked for updated publication information.

On March 11, 2020, the World Health Organization (WHO) (Geneva, Switzerland) declared a pandemic due to the quick spread of a respiratory disease caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). With positive cases growing in multiple countries and due to its high transmissibility, eradicating SARS-CoV-2 is rather unrealistic in the short term 1 . In Switzerland, the second wave of the SARS-CoV-2 is predicted to be slower than the first one, but with a higher case fatality rate 2 In March 2020, an in-house platform for SARS-CoV-2 diagnostics was initiated as part of an emergency response to a growing demand for test capacity in a routine microbiology laboratory at University hospital in Zurich. Currently, the gold standard for the detection and diagnosis of SARS-CoV-2 infection is based on the real-time reverse transcription PCR (RT-PCR). The overall goal was to provide in-house SARS-CoV-2 diagnosis to all patients and personnel, to ensure the safe and efficient continuation of the health care work within the hospital and the protection of high-risk patients. The aims of this study were: i) to evaluate four commercially available, one customized, and one in-house RT-PCR test by comparing the limit of detection (LoD), sensitivity using a panel of SARS-CoV-2 confirmed cases, and specificity using a group of non-COVID respiratory samples; ii) to examine the feasibility of down-scaling two commercial protocols in order to optimize the testing capacity; iii) to develop a droplet digital PCR (ddPCR) assay to increase test sensitivity and provide more accurate quantitation of viral RNA; and iv) to examine applicability of two validated RT-PCR protocols as well as of a ddPCR protocol on SARS-CoV-2 environmental samples. 

Four commercially available, one customized from Pasteur Institute and in-house optimized RT-PCR protocols (description available in Table 1 ) 6,7 were compared. Primer probes design, reaction mix and thermal cycling conditions are shown in Table 2 

The droplet digital PCR (ddPCR) protocol for SARS-CoV-2 detection targets two viral genomic regions of the SARS-CoV-2 gene (ORF1ab and N2) and uses the human RNase P gene as an in-process control. Following probes for the three genes were used: ORF1ab (FAM and HEX), N2 (FAM) and

RNase P (HEX) (primer sequences can be found in Table 2 DdPCR was run according to the program shown in Table 5 

The viral infectivity assay was performed as previously described 8 The six RT-PCR protocols compared in this study utilize the same principle of isolating viral RNA from the nasopharyngeal and/or oropharyngeal swabs or bronchial fluid and running a 1-step reverse transcription reaction followed by real time amplification of two or three SARS-CoV-2 target genes ( Figure 1 ). Summary and comparison of all tested RT-PCR protocols is shown in Table 6 . All protocols have internal (IC), non-template (NTC) and positive controls (PC). In TF-MultiPlex, the phage MS2 is added as IC that serves as both RNA isolation and reaction control. All other protocols except for Euroimmun (where type of IC is not indicated) use a widely accepted reaction control RNAseP to ensure that RNA isolation worked and RT-PCR reaction was not inhibited. Protocol's design are either singleplex, doubleplex or multiplex. Euroimmun protocol stands out with its design, with two target probes coupled to the same reporter color FAM. The viral RNA input is 5μL to 10μL.

Due to unspecific E-gene amplification (Supplemental Table S1 ), the protocol developed by Pasteur institute in Paris was not used further in this comparative study.

With a Ct-value cut-off of 40, the five RT-PCR SARS-CoV-2 detection protocols (CDC, TF-MultiPlex, TF-SinglePlex, Euroimmun, Oncobit) as well as Oncobit ddPCR protocol showed limit of detection (LoD) between 1 and 2 viral copies/μL (Figure 2A, B) . Values below 1 copy/μL indicate high sensitivity of the tested protocol (Figure 2A Table S2 ). The specificity was thus 100% for all protocols except for TF-SinglePlex, which had a specificity of 98.7% ( Figure 3A ).

Inconclusive results were found in 0.5-3.2% of these 184 samples, with TF-MultiPlex and Oncobit providing the most accuracy ( Figure 3A ). Comparing RT-PCR results (positive, negative, inconclusive) of all 184 samples, the overall non-concordance between all the protocols was 14.7% ( Figure 3B ).

To optimize testing capacity, (i) recommended reaction volumes in commercial protocols were downscaled and (ii) published primer/probe sequences were customized to have an in-house developed protocol (Oncobit). Using a previously confirmed SARS-CoV-2 positive cohort of 14 samples, CDC and TF-MultiPlex protocols with recommended reaction volume and with reaction volumes reduced by 50% were compared. RNA sample input was always the same. The Oncobit protocol was the cheapest (Table 6) , had the shortest RT-PCR reaction time requirement (Table 6 ) and had most reliable access to consumables (Microsynth). The specificity and sensitivity of the Oncobit protocol was comparable to other commercial SARS-CoV-2 RT-PCR detection kits ( Figure 3A,B) .

A downscaled CDC protocol showed two (14.3%) inconclusive results, a standard TF-MultiPlex protocol showed one (7.1%) false negative result, and a downscaled TF-MultiPlex protocol revealed one (7.1%) false negative as well as one (7.1%) inconclusive result ( Figure 4A ). Furthermore, LoD of downscaled CDC and TF-MultiPlex protocols showed a sensitivity of 1 copy/μL with a Ct-value cut-off of 40 ( Figure   4B ). Table S3 ), while no infectivity for any of the samples was detected (Supplemental Figure S1B ).

Real time RT-PCR remains the most sensitive method for early detection of SARS-CoV-2. Here, we report a comparison of LoD, specificity, sensitivity, economic, and practical advantages of four commercial SARS-CoV-2 detection kits as well as one optimized in house RT-PCR SARS-CoV-2 protocol.

A study comparing RT-PCR to rapid fluorescence immunochromatographic (FIC) assay-based SARS-CoV-2 Nucleocapsid protein (NP) antigen detection method showed that sensitivity of the rapid method was only around 75.6% 11 , therefore RT-PCR remains a more sensitive detection method for SARS-CoV-2. Most of the reported multiplatform comparison studies on real time RT-PCR SARS-CoV-2 detection performed the benchmarking only on limited number of samples and tested only commercial detection kits 10, 12, 13 , and some studies limited the comparison only to sensitivity assessment 14 .

In this study, a low LoD and high sensitivity for four commercial SARS-CoV-2 RT-PCR detection protocols were observed by using standard quantitative test samples and a cohort of 92 SARS-CoV-2 positive samples, respectively. Furthermore, specificity of those protocols was tested and confirmed with 92 samples that either had confirmed SARS-CoV-2 negative result or were collected in prepandemic times from patients presenting with respiratory symptoms (listed in Supplemental Table S2 ).

Additionally, downscaling of two commercial protocols that were chosen for the diagnostic routine (CDC and TF-MultiPlex), could be an option to save resources. This is especially important in times when a high demand for SARS-CoV-2 testing causes supply chain problems as occurred at the beginning of J o u r n a l P r e -p r o o f the pandemic in Europe. As an alternative strategy to optimize costs and increase testing capacity, an in-house protocol was developed in collaboration with the diagnostics company Oncobit by adapting previously published primer sequences for multiplex analysis. The customized Oncobit potocol was the least costly and fastest protocol when compared to other commercial RT-PCR protocols tested in this study.

To expand the application of RT-PCR based detection protocols, a testing of swabbed surfaces from a SAR-CoV-2 quarantined household was performed. Results showed that RT-PCR protocols detected the viral genetic material on the laptop keyboard and this result was confirmed by a more sensitive ddPCR method. Two more surfaces showed inconclusive results (a newspaper and a door handle, with viral copies detectable by ddPCR, however below the limit of detection (Supplemental Table S3 ).

Nasopharyngeal swab taken on the same day tested positive, however infectivity assay for all samples showed negative results. This demonstrates possibility to apply the RT-PCR based protocols on nonpatient samples that could be of use for larger environmental studies.

Summarizing the comparative study, we demonstrated that most commercial and customized RT-PCR based detection protocols are highly effective at detecting viral presence in classical nasopharyngeal and/or oropharyngeal swabs and due to its high sensitivity can be applied to testing of environmental samples.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f N2 probe (FAM) 5'-ACAATTTGCCCCCAGCGCTTCA-3'

ORF1ab forward primer 5'-CCCTGTGGGTTTTACACTTAA-3'

ORF1ab reverse primer 5'-ACGATTGTGCATCAGCTGA-3'

ORF1ab probe (Cy5) 5'-CCGTCTGCGGTATGTGGAAAGGTTATGG-3'

RNaseP forward primer 5'-AGATTTGGACCTGCGAGCG-3'

RNaseP probe (HEX) 5'-TTCTGACCTGAAGGCTCTGCGCG-3'

TaqPath J o u r n a l P r e -p r o o f

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

Age-stratified discrete compartment model of the COVID-19 epidemic with application to Switzerland

Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review

Comparison of RNA extraction methods for the detection of SARS-CoV-2 by RT-PCR

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR

Virucidal and Neutralizing Activity Tests for Antiviral Substances and Antibodies

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Chu References are updated according to the Journal style. Non-literature sources are moved into the manuscript text and the accession date is indicated in brackets. Citations from pre-print services

Gene symbols, loci, alleles, and genotypes should be styled in italic, while proteins, gene products, phenotypes, mRNAs, and cDNAs should not

Comparative performance of SARS-CoV-2 real-time PCR diagnostic assays on samples from

Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

Age-stratified discrete compartment model of the COVID-19 epidemic with application to Switzerland

Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review

Comparison of RNA extraction methods for the detection of SARS-CoV-2 by RT-PCR

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR

Virucidal and Neutralizing Activity Tests for Antiviral Substances and Antibodies

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Comparative tropism, J o u r n a l P r e -p r o o f replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection

Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens

We thank Gaetana Restivo for help with obtaining ethical clearance for the study. We are very grateful